Mar 19, 2013 – The US Food and Drug Administration (FDA) has completed its review of Pharmaxis’ New Drug Application (NDA) for its dry powder formulation of mannitol (Bronchitol, Pharmaxis) and has recommended that the company conduct an additional study to obtain Continue reading FDA Sends Cystic Fibrosis Treatment Back for More Study
N30 Pharmaceuticals Inc. in Boulder announced Wednesday that it has administered, in a clinical trial, the first dose of a drug designed to treat cystic fibrosis.
The drug, labeled N6022, was administered this week to a patient at National Jewish Health in Denver. Continue reading Cystic-fibrosis drug gets first clinical trial
Published on March 1, 2013 at 12:00 AM
Chronic or acute, liver failure can be deadly. Toxins take over, the skin turns yellow and higher brain function slows.
“There is no effective therapy at the moment to deal with the toxins that build up in your body,” Continue reading Stem cell line could also advance research into liver cancers, cystic fibrosis
Last April, after being told that only a transplant could save her from a fatal lung condition, Rebecca S. Tomczak began calling some of the top-ranked hospitals in the country.
She started with Emory University Hospital in Atlanta, just hours from her home near Augusta, Ga. Then she tried Duke and the University of Arkansas and Johns Hopkins. Each advised Ms. Continue reading ‘Bloodless’ Lung Transplants Offer Hint at Surgery’s Future